APA (7th ed.) Citation

Sbergio, S., Liang, P., Beilhartz, G., Patel, P., Vadivel, A. A., Melnyk, R., & Hawkins, C. (2023). EXTH-47. TUMOUR-TARGETED PAN-RAS INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). Neuro-oncology (Charlottesville, Va.), 25(Supplement_5), v235. https://doi.org/10.1093/neuonc/noad179.0900

Chicago Style (17th ed.) Citation

Sbergio, Stefanie-Grace, Peter Liang, Greg Beilhartz, Palak Patel, Arun Anguraj Vadivel, Roman Melnyk, and Cynthia Hawkins. "EXTH-47. TUMOUR-TARGETED PAN-RAS INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)." Neuro-oncology (Charlottesville, Va.) 25, no. Supplement_5 (2023): v235. https://doi.org/10.1093/neuonc/noad179.0900.

MLA (9th ed.) Citation

Sbergio, Stefanie-Grace, et al. "EXTH-47. TUMOUR-TARGETED PAN-RAS INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)." Neuro-oncology (Charlottesville, Va.), vol. 25, no. Supplement_5, 2023, p. v235, https://doi.org/10.1093/neuonc/noad179.0900.